Trials / Sponsors / JenKem Technology Co., Ltd.
JenKem Technology Co., Ltd.
Industry · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases Triple Negative Breast Cancer (TNBC), Brain Metastasases | Phase 2 | 2024-09-26 |
| Not Yet Recruiting | JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer Small Cell Lung Cancer | Phase 3 | 2024-09-16 |
| Recruiting | JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM) Glioblastoma Multiforme (GBM) | Phase 2 | 2022-10-31 |
| Unknown | Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLC Small Cell Lung Cancer (SCLC) | Phase 1 / Phase 2 | 2021-11-11 |
| Completed | Safety, Tolerability and Pharmacokinetics of Injectable PEG-Irinotecan (JK-1201I) in Patients with Malignant S Solid Tumor | Phase 1 | 2018-05-04 |